Atlas Trials

Parainfluenza Virus 3, Human

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Parainfluenza Virus 3, Human

RecordFirmDate
Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children (NCT01254175)National Institute of Allergy and Infectious Diseases (NIAID)2010-12-01
Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age (NCT00493285)MedImmune LLC2007-07-01

Track Parainfluenza Virus 3, Human automatically

Every clearance here is in the API, with alerts when new ones post.